Efficient radiosynthesis and preclinical evaluation of [18F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging

被引:7
|
作者
Singleton, Thomas A. [1 ]
Bdair, Hussein [1 ,4 ]
Bailey, Justin J. [2 ]
Choi, Sangho [2 ]
Aliaga, Arturo [3 ]
Rosa-Neto, Pedro [1 ,3 ,4 ]
Schirrmacher, Ralf [2 ]
Bernard-Gauthier, Vadim [2 ]
Kostikov, Alexey [1 ,4 ]
机构
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Univ Alberta, Dept Oncol, Div Oncol Imaging, Edmonton, AB, Canada
[3] Douglas Mental Hlth Univ Inst, McGill Ctr Studies Aging, Translat Neuroimaging Lab, Montreal, PQ, Canada
[4] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
关键词
F-18]FOMPyD; brain imaging; colony stimulating factor receptor (CSF-1R); copper-mediated F-18-fluorination; fluorine-18; GW2580; PET; positron emission tomography; tropomyosin receptor kinase (Trk); INHIBITOR;
D O I
10.1002/jlcr.3827
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Herein we report an efficient radiolabeling of a F-18-fluorinated derivative of dual inhibitor GW2580, with its subsequent evaluation as a positron emission tomography (PET) tracer candidate for imaging of two neuroreceptor targets implicated in the pathophysiology of neurodegeneration: tropomyosin receptor kinases (TrkB/C) and colony stimulating factor receptor (CSF-1R). [F-18]FOMPyD was synthesized from a boronic acid pinacolate precursor via copper-mediated F-18-fluorination concerted with thermal deprotection of the four Boc groups on a diaminopyrimidine moiety in an 8.7 +/- 2.8% radiochemical yield, a radiochemical purity >99%, and an effective molar activity of 187 +/- 93 GBq/mu mol. [F-18]FOMPyD showed moderate brain permeability in wild-type rats (SUVmax = 0.75) and a slow washout rate. The brain uptake was partially reduced (Delta AUC(40-90) = 11.6%) by administration of the nonradioactive FOMPyD (up to 30 mu g/kg). In autoradiography, [F-18]FOMPyD exhibits ubiquitous distribution in rat and human brain tissues with relatively high nonspecific binding revealed by self-blocking experiment. The binding was blocked by TrkB/C inhibitors, but not with a CSF-1R inhibitor, suggesting selective binding to the former receptor. Although an unfavorable pharmacokinetic profile will likely preclude application of [F-18]FOMPyD as a PET tracer for brain imaging, the concomitant one-pot copper-mediated F-18-fluorination/Boc-deprotection is a practical technique for the automated radiosynthesis of acid-sensitive PET tracers.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [41] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    Barthel, H
    Wilson, H
    Collingridge, DR
    Brown, G
    Osman, S
    Luthra, SK
    Brady, F
    Workman, P
    Price, PM
    Aboagye, EO
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2232 - 2242
  • [42] Radionuclide impurities in [18F]F- and [18F]FDG for positron emission tomography
    Koehler, M.
    Degering, D.
    Zessin, J.
    Fuechtner, F.
    Konheiser, J.
    APPLIED RADIATION AND ISOTOPES, 2013, 81 : 268 - 271
  • [43] Positron emission tomography with [18F]-FDG in oncology
    Talbot, JN
    Petegnief, Y
    Kerrou, K
    Montravers, F
    Grahek, D
    Younsi, N
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2003, 504 (1-3) : 129 - 138
  • [44] Evaluation of (2S,4S)-4-[18F]FEBGln as a Positron Emission Tomography Tracer for Tumor Imaging
    Huang, Yong
    Liu, Yajing
    Li, Chengze
    Li, Zhongjing
    Chen, Hualong
    Zhang, Lu
    Liang, Ying
    Wu, Zehui
    MOLECULAR PHARMACEUTICS, 2023, 20 (10) : 5195 - 5205
  • [45] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    H Barthel
    H Wilson
    D R Collingridge
    G Brown
    S Osman
    S K Luthra
    F Brady
    P Workman
    P M Price
    E O Aboagye
    British Journal of Cancer, 2004, 90 : 2232 - 2242
  • [46] Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
    Alexander Thiel
    Alexey Kostikov
    Hailey Ahn
    Youstina Daoud
    Jean-Paul Soucy
    Stephan Blinder
    Carolin Jaworski
    Carmen Wängler
    Björn Wängler
    Freimut Juengling
    Shirin A. Enger
    Ralf Schirrmacher
    EJNMMI Radiopharmacy and Chemistry, 8
  • [47] Synthesis and evaluation of [18F]-fluoromethyl triphenylphosphonium cation as a novel mitochondria-specific positron emission tomography tracer
    Zeng, Huahui
    Wu, Xiangxiang
    Song, Fahuan
    Xu, Caiyun
    Liu, Hao
    Liu, Wendi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 118 : 90 - 97
  • [48] Biological Evaluation of [18F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma
    Lin, Liping
    Xiang, Xianhong
    Su, Shu
    Liu, Shaoyu
    Xiong, Ying
    Ma, Hui
    Yuan, Gongjun
    Nie, Dahong
    Tang, Ganghua
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [49] Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
    Thiel, Alexander
    Kostikov, Alexey
    Ahn, Hailey
    Daoud, Youstina
    Soucy, Jean-Paul
    Blinder, Stephan
    Jaworski, Carolin
    Waengler, Carmen
    Waengler, Bjoern
    Juengling, Freimut
    Enger, Shirin A.
    Schirrmacher, Ralf
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [50] [18F]Fluorodeoxyglucose positron emission tomography in advanced thyroid cancer
    Taieb, D.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (05): : 329 - 331